According to the CDC – Researchers are still undergoing drug trials.
NO drugs or other therapeutics approved by the US Food and Drug Administration to prevent or treat COVID-19.
Current clinical management includes:
infection prevention and control measures
supportive care, including:
supplemental oxygen and mechanical ventilatory support when indicated.
Remdesivir
– inhibits viral replication through premature termination of RNA transcription and has in-vitro activity against SARS-CoV-2 and in-vitro and in-vivo activity against related beta coronaviruses.
Hydroxychloroquine and chloroquine
are oral prescription drugs that have been used for the treatment of malaria and certain inflammatory conditions.
in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection, and treatment of patients with mild, moderate, and severe COVID-19.
Several other drugs
(e.g., investigational antivirals, immunotherapeutic, host-directed therapies) are under investigation in clinical trials or are being considered for clinical trials of pre-exposure prophylaxis, post-exposure prophylaxis, or treatment of COVID-19 in the United States and worldwide.
